Notwithstanding their strengths, it has been observed that in individuals with CD4 T cell counts below 350 cells/mL or with AIDS-defining events at diagnosis, mutations that result in the failure of this drug class may accumulate, both in treatment-experienced and treatment-naïve patients. Here, CD4 is linked to AIDS.